Every Issue

Note from the Hepatitis C Editor
Dare to dream

Front Cover Backstory
Personal motivation

The Category Is July+August 2021
Long-term realness

Briefly July+August 2021
A long-acting medication now being used once a month for HIV may soon be used every other month for HIV prevention.

Poz Advocate July+August 2021
Knocking down myths regarding blood donation policy

Positively Aging July+August 2021
Working it
This Issue

Health Equity
Health equity, social justice, and HIV in the era of George Floyd and COVID-19
Hepatitis Drug Guide

Living with Hepatitis C
Stories of stigma and getting cured

What do you think is needed for the U.S. to achieve viral hepatitis elimination?
There are so many amazing people working to improve the lives of people living with viral hepatitis, including many of the authors of articles in this issue.

How to use this guide
The Positively Aware Viral Hepatitis Drug Guide includes medications for the treatment of hepatitis B (HBV) and hepatitis C (HCV) that are FDA approved. The information provided comes from the package labels, as well as sources such as the AASLD/IDSA Recommendations for Testing, Managing, and Treating Hepatitis C (HCV Guidance) and AASLD Hepatitis B Guidance.

HCV FAQs
PA’s hepatitis editor Andrew Reynolds answers frequently asked questions about hepatitis C—what you should know

HCV Drug Table
Hepatitis C Direct-Acting Antivirals (DAAs)

HCV co-pay and resources
Hepatitis C co-pay and patient assistance programs

HCV-HIV co-infection
Hepatitis C treatment for HIV/HCV co-infected persons

To treat, or not to treat?
The answer is yes—people who inject drugs should be treated for their hepatitis C

Hepatitis B—An overview
A cheat sheet from Andrew Reynolds on the most common infectious disease in the world

Hepatitis B medications
Preferred regimens based on AASLD treatment guidelines

Black Box Warning
Hepatitis B reactivation

HBV Co-Pay & Resources
Hepatitis B Medication Patient Assistance Programs

Hepatitis D
Wait…there’s another hepatitis virus?